Paper6203605
Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat.
Seiler M and 1 other. Brain Res, 1984. Cited by 515 papers, by iCite.
Cite this record
ConductScience Library. Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat. Papers, record 6203605. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6203605
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Basal Ganglia | Major topic |
| Cerebral Cortex | Major topic |
| Hippocampus | Major topic |
| Nerve Growth Factors | Major topic |
| Substantia Innominata | Major topic |
| Animals | |
| Axonal Transport | |
| Brain Mapping | |
| Cholinergic Fibers | |
| Female | |
| Frontal Lobe | |
| Neural Pathways | |
| Occipital Lobe | |
| Rats | |
| Rats, Inbred Strains |
Source PubMed
Cited by78
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 515 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42679819 | Cross-species single-cell atlas of the striatum defines cell-type and subregion disease vulnerabilities. | Cell | 2026 | https://conductscience.org/library/papers/42679819 | PubMed |
| 37808473 | Enhanced TrkA signaling impairs basal forebrain-dependent behavior. | Front Mol Neurosci | 2023 | https://conductscience.org/library/papers/37808473 | PubMed |
| 36453397 | Neurotrophic factor-based pharmacological approaches in neurological disorders. | Neural Regen Res | 2023 | https://conductscience.org/library/papers/36453397 | PubMed |
| 35741668 | Targeting the Cation-Chloride Co-Transporter NKCC1 to Re-Establish GABAergic Inhibition and an Appropriate Excitatory/Inhibitory Balance in Selective Neuronal Circuits: A Novel Approach for the Treatment of Alzheimer's Disease. | Brain Sci | 2022 | https://conductscience.org/library/papers/35741668 | PubMed |
| 35681529 | A Microglial Function for the Nerve Growth Factor: Predictions of the Unpredictable. | Cells | 2022 | https://conductscience.org/library/papers/35681529 | PubMed |
| 35431894 | Alzheimer's Disease: An Update and Insights Into Pathophysiology. | Front Aging Neurosci | 2022 | https://conductscience.org/library/papers/35431894 | PubMed |
| 35412281 | Retrograde Axonal Transport of Neurotrophins in Basal Forebrain Cholinergic Neurons. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/35412281 | PubMed |
| 35360160 | Getting Into the Brain: The Intranasal Approach to Enhance the Delivery of Nerve Growth Factor and Its Painless Derivative in Alzheimer's Disease and Down Syndrome. | Front Neurosci | 2022 | https://conductscience.org/library/papers/35360160 | PubMed |
| 35023028 | Neuroprotective role of Diosgenin, a NGF stimulator, against Aβ (1-42) induced neurotoxicity in animal model of Alzheimer's disease. | Metab Brain Dis | 2022 | https://conductscience.org/library/papers/35023028 | PubMed |
| 34867367 | Intranasal Delivery of Nerve Growth Factor in Neurodegenerative Diseases and Neurotrauma. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34867367 | PubMed |
| 34453296 | Rita Levi-Montalcini, NGF Metabolism in Health and in the Alzheimer's Pathology. | Adv Exp Med Biol | 2021 | https://conductscience.org/library/papers/34453296 | PubMed |
| 34440751 | Effects of Reactive Oxygen and Nitrogen Species on TrkA Expression and Signalling: Implications for proNGF in Aging and Alzheimer's Disease. | Cells | 2021 | https://conductscience.org/library/papers/34440751 | PubMed |
| 33321704 | Involvement of Bradykinin Receptor 2 in Nerve Growth Factor Neuroprotective Activity. | Cells | 2020 | https://conductscience.org/library/papers/33321704 | PubMed |
| 31133787 | Exploring the Pathogenesis of Alzheimer Disease in Basal Forebrain Cholinergic Neurons: Converging Insights From Alternative Hypotheses. | Front Neurosci | 2019 | https://conductscience.org/library/papers/31133787 | PubMed |
| 30853882 | ProNGF and Neurodegeneration in Alzheimer's Disease. | Front Neurosci | 2019 | https://conductscience.org/library/papers/30853882 | PubMed |
| 30809111 | The Brain NGF Metabolic Pathway in Health and in Alzheimer's Pathology. | Front Neurosci | 2019 | https://conductscience.org/library/papers/30809111 | PubMed |
| 29651949 | Nerve Growth Factor: Early Studies and Recent Clinical Trials. | Curr Neuropharmacol | 2018 | https://conductscience.org/library/papers/29651949 | PubMed |
| 27815842 | Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy. | Mol Neurobiol | 2017 | https://conductscience.org/library/papers/27815842 | PubMed |
| 26836322 | Exercise leads to the re-emergence of the cholinergic/nestin neuronal phenotype within the medial septum/diagonal band and subsequent rescue of both hippocampal ACh efflux and spatial behavior. | Exp Neurol | 2016 | https://conductscience.org/library/papers/26836322 | PubMed |
| 24861506 | Platelet-derived nerve growth factor supports the survival of cholinergic neurons in organotypic rat brain slices. | Neurosci Lett | 2014 | https://conductscience.org/library/papers/24861506 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6203605
GET https://conductscience.org/api/papers/v1/6203605/cited_by?page=2